Italy will bring innovative SMEs and start-ups, a core part of the country’s offering, at the Arab Health 2021
Set to be one of the biggest attractions at the event, Italian producers will be offering advanced solutions to some of the world’s most pressing health and wellness issues.
Italy is currently ranked as the number one producer for medicine and drugs in the EU, with a pharmaceutical turnover of US$37bn, plus, the country has one of the highest growth rates of investment in R&D in the sector. Italy is not only competitive in the global market, but is also the eighth largest world economy and the second manufacturing economy in the EU.
Italy’s spotlight on the country’s healthcare SMEs and start-ups at this year’s Arab Health, follows the Italian government’s sponsorship of a one billion Euros investment programme aimed at the native startup ecosystem in June 2020. As a result, the number of Italian start-up companies has boomed over the past year, with 13,000 start-ups now registered in Italy as of December 2020.
HE Nicola Lener, ambassador of Italy to the UAE, who will be attending the exhibition commented on the strong trade relationship that Italy has with the UAE, “Life Sciences are today one of Italy’s leading sectors, with an integrated ecosystem spanning from pharmaceuticals to medical devices, from regenerative medicine to precision health and diagnostics, from biotechnological research to genomics, from telemedicine to robotics, and also the development of software and data analysis tools.
“At Arab Health, Italian companies will be demonstrating their innovation capabilities – which have been further boosted by the disruption caused by the pandemic – and will be looking to increase their support of the expanding healthcare sector in the UAE and the wider region.”
Fifty-one Italian companies, including eight innovative start-ups selected by ITA in its official pavilion, will be present at Arab Health, which is taking place in-person from 21-24 June at the Dubai World Trade Centre.
